102 related articles for article (PubMed ID: 16159042)
1. Pledging for accutane.
Healy B
US News World Rep; 2005 Sep; 139(8):63. PubMed ID: 16159042
[No Abstract] [Full Text] [Related]
2. Trends in adherence to a revised risk management program designed to decrease or eliminate isotretinoin-exposed pregnancies: evaluation of the accutane SMART program.
Brinker A; Kornegay C; Nourjah P
Arch Dermatol; 2005 May; 141(5):563-9. PubMed ID: 15897377
[TBL] [Abstract][Full Text] [Related]
3. The new teratogens: accutane and other vitamin-A analogs.
Thomson EJ; Cordero JF
MCN Am J Matern Child Nurs; 1989; 14(4):244-8. PubMed ID: 2501615
[No Abstract] [Full Text] [Related]
4. Oral isotretinoin: prescribers beware.
Shear NH
CMAJ; 1999 Jun; 160(12):1723-4. PubMed ID: 10410636
[No Abstract] [Full Text] [Related]
5. Fetal exposure to oral isotretinoin: failure to comply with the Pregnancy Prevention Program.
Atanackovic G; Koren G
CMAJ; 1999 Jun; 160(12):1719-20. PubMed ID: 10410634
[No Abstract] [Full Text] [Related]
6. Accutane registry compulsory in US, but not Canada.
Andresen M
CMAJ; 2006 Jun; 174(12):1701. PubMed ID: 16754892
[No Abstract] [Full Text] [Related]
7. Potential subversion of pregnancy prevention program in the managed care setting.
Wilkin JK
Arch Dermatol; 1997 Feb; 133(2):243-4. PubMed ID: 9041846
[No Abstract] [Full Text] [Related]
8. A survey of pregnant women using isotretinoin.
Robertson J; Polifka JE; Avner M; Chambers C; Delevan G; Koren G; Lavigne SV; Martinez LP; Miller RK; Carey JC
Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):881-7. PubMed ID: 16228976
[TBL] [Abstract][Full Text] [Related]
9. Babies, bath water, and accutane.
Stone SP
Clin Dermatol; 2001; 19(1):91-2. PubMed ID: 11369494
[No Abstract] [Full Text] [Related]
10. Isotretinoin and pregnancy.
Jones KL; Adams J; Chambers CD; Erickson JD; Lammer E; Polifka J;
JAMA; 2001 Apr; 285(16):2079-81. PubMed ID: 11311094
[No Abstract] [Full Text] [Related]
11. Restriction of the use of drugs with teratogenic properties: Swedish experiences with isotretinoin.
Källén B
Teratology; 1999 Aug; 60(2):53. PubMed ID: 10440771
[No Abstract] [Full Text] [Related]
12. [Accutane (isotretinoic acid)--a new human teratogen].
Kucera J
Cesk Gynekol; 1985 Jul; 50(6):418-9. PubMed ID: 3861266
[No Abstract] [Full Text] [Related]
13. Accutane Roche: risk of teratogenic effects.
Zarowny DP
Can Med Assoc J; 1984 Aug; 131(4):273. PubMed ID: 6589028
[No Abstract] [Full Text] [Related]
14. Accutane cases: a teratogen information service's approach.
Robertson JA; Martinez LP; Gallegos S; Leen-Mitchell MJ; Garcia V; Neuman J; Carey JC
Teratology; 2002 Jul; 66(1):1-2. PubMed ID: 12115772
[No Abstract] [Full Text] [Related]
15. The cost of clear skin: balancing the social and safety costs of iPLEDGE with the efficacy of Accutane (isotretinoin).
Doshi A
Seton Hall Law Rev; 2007; 37(2):625-60. PubMed ID: 17294569
[No Abstract] [Full Text] [Related]
16. [Summary of the practice guideline 'Acne' (second revision) from the Dutch College of General Practitioners].
de Vries LC
Ned Tijdschr Geneeskd; 2008 Nov; 152(45):2482. PubMed ID: 19054867
[No Abstract] [Full Text] [Related]
17. The broader message of accutane.
Shulman SR
Am J Public Health; 1989 Nov; 79(11):1565-8. PubMed ID: 2817177
[No Abstract] [Full Text] [Related]
18. Pregnancy prevention among women taking isotretinoin: failure to comply with the recommendations.
Boucher N; Beaulac-Baillargeon L
Can Fam Physician; 2006 Mar; 52(3):338-9. PubMed ID: 16926960
[TBL] [Abstract][Full Text] [Related]
19. [Isotretinoin embryopathy. Report of one case].
Troncoso Sch M; Rojas H C; Bravo C E
Rev Med Chil; 2008 Jun; 136(6):763-6. PubMed ID: 18769834
[TBL] [Abstract][Full Text] [Related]
20. The way women perceive teratogenic risk.
Koren G
Can J Clin Pharmacol; 2007; 14(1):e10-6. PubMed ID: 17213504
[No Abstract] [Full Text] [Related]
[Next] [New Search]
